✨
AI Summary
- J&J's oncology prospects and GSK's Rapt acquisition are discussed.
- Key drug launches for 2026 and J.P. Morgan's financial outlook.
- Scrip analyzes competitive dynamics in the biopharma landscape.
Citeline Podcasts